rejuvant life tabs
rejuvant life tabs

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...

Latest news

Longevity supplements report: JUVICELL profile

Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement. Over the coming weeks, we will be bringing...

New perspective in gerontology: epigenetic rejuvenation

Can biological age be set back by "making the clock tick backwards"? Scientists suggest that a partial phenotypic rejuvenation can be gained. Since the discovery...

Gerostate Alpha opens crowdfunded capital raise

Buck Institute-founded start-up Gerostate Alpha seeks to crowdfund its biotech platform. When Y Combinator so likes your ideas, it gives you $1 million to start...

BioAge licenses Amgen drug to treat muscle aging

Exclusive deal to develop and commercialise Amgen’s Phase 1 APJ agonist, after BioAge platform identifies its potential in promoting longevity and reducing symptoms of...

Can leucine turbo-charge longevity supplements and drugs?

Our exclusive interview with NuSirt’s founder explores how combining the sirtuin-activating amino acid has the potential to enhance the effect of longevity supplements and...
Supps report ad middle

Diagnostics

New perspective in gerontology: epigenetic rejuvenation

Can biological age be set back by "making the clock tick backwards"? Scientists suggest that a partial phenotypic rejuvenation can be gained. Since the discovery...

First non-invasive biomarker to track and verify senolytics

Researchers at The Buck Institute develop a biomarker test for senolytics, paving the way for senotherapeutic treatments. Buck Institute researchers have discovered and are developing...

Bats’ contribution to DNA methylation research

New research into DNA methylation to accurately predict maximum lifespan and support longevity R&D. The study of reversible DNA modifications, known as epigenetics, has played...
Rejuvant

Biotech

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the...

New perspective in gerontology: epigenetic rejuvenation

Can biological age be set back by "making the...

BioAge licenses Amgen drug to treat muscle aging

Exclusive deal to develop and commercialise Amgen’s Phase 1...

Investment

Longevity “top of my agenda” says Silicon Valley Bank VP

Flavia Popescu-Richardson talks longevity investment and how venture debt financing can benefit early stage companies. The longevity sector is expanding with early-stage companies and, although...

“Whole-body mitochondrial transfusion” start-up lands funding

Mitrix wants to create biobanks of our “young mitochondria” that we can use to help our cells regenerate as we age. Californian start-up Mitrix this...

Harvard spin-off Cellvie Inc closes $5M seed round

Kizoo leads $5M seed round at Harvard spin-off Cellvie in pursuit of new treatment modality: Therapeutic Mitochondria Transfer (TMT). Harvard spin-off Cellvie Inc has closed...

Senolytic start-up gears up for clinical trials

Rubedo’s first target is respiratory disease, with COVID-19 expected to drive an increase in lung disease over the next 10 years.   Late last year,...

Gerostate Alpha: “Our phenotype is lifespan”

Buck Institute start-up's founders talk drug discovery, indications and raising funding. Following yesterday's introduction to Gerostate Alpha, today we continue our interview with two of...

Most popular articles

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...

Aubrey de Grey: Methuselarity by 2035 – and it’ll be free

Aubrey de Grey tells Longevity.Technology the revolution is coming, and everyone will be eligible. "I now think there is a 50% chance that we will...

Video

Exclusive video interview: David Wood demystifies the transhumanist agenda

As Longevity moves quickly into the mainstream there are terms and legacies that some use to challenge the sector's validity: we explore what it...

The Big Picture: Covid-19 and Longevity investing

Jim Mellon, Chairman and Founder, Burnbrae Group

Video interview: talking senescence with Nina Khera

Teenage founder of Canadian start-up Biotein hunts a universal phenotype for senescent cells. As we’ve covered in the past, Biotein’s Nina Khera has a mission...

Innovation

Renal fibrosis caused by telomere shortening – new research

CNIO researchers demonstrate that renal fibrosis is caused by telomere shortening, paving the way for future treatment. Researchers in the...

Successful free radical therapy? Targeting is key

SFRRI President-Elect Giovanni Mann reveals why targeting cellular antioxidant pathways needs to be as precise as possible – and...

Economy

New research institute focuses on science of aging

New Bakar Aging Research Institute aims to drive deeply collaborative research to enhance translational medicine, progressing novel therapies from lab to clinic to community. UC...

Call for £3b intervention to save lives and back health

"Levelling Up Health" Ten Year Plan would save 40,000 lives from next pandemic says cross party group, as it calls for £3 billion intervention...

Juvenescence appoints Chief Scientific Officer

Innovative biotech Juvenescence has announced it has appointed Dr Grazia Piizzi as its Chief Scientific Officer. Juvenescence Ltd, a life sciences company focused on modifying...

Jobs in longevity? Your new career starts here

Announcing our new 'jobs in longevity' system and international 'executive search' service. As many of us enter a long-weekend there'll be some downtime to consider...
Supplement report
Supps report ad middle

Supplements

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Longevity supplements report: JUVICELL profile

Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement. Over the coming weeks, we will be bringing...

Can leucine turbo-charge longevity supplements and drugs?

Our exclusive interview with NuSirt’s founder explores how combining the sirtuin-activating amino acid has the potential to enhance the effect of longevity supplements and...

Longevity supplements report: PDLH profile

The company behind Rejuvant, which partnered with the Buck Institute for Research on Aging on its calcium alpha-ketoglutarate longevity supplement. Over the coming weeks, we...

AI/Digital

Connected care start-up targets aging-in-place

PCL Health monitors key vitals at home, providing caregivers...

Gut bacteria start-up exits stealth with unique data

Wild Biotech plans to use database of more than...

AI first: novel drug target and novel molecule discovered

One step closer to senescence moonshot: Insilico claims industry...

Agetech

New investor offers funding to healthy aging innovators

A fifth investor has joined UK Research and Innovation (UKRI), providing matched funding for top small innovators to develop ideas for healthy aging. The new...

Connected care start-up targets aging-in-place

PCL Health monitors key vitals at home, providing caregivers with peace of mind and supporting aging-in-place. British start-up PCL Health (formerly Poonyah Care) is on...

AgeTech fund: focus on over-50s not millennials

Founding partner of 1843 Capital targets AgeTech investment opportunities with $13 million fund. Connecticut-based early stage investment firm 1843 Capital values diversity highly, and seeks...

Fall detection tech a focus for investors

EchoCare raising funds to target acute fall detection and other emergencies with privacy-sensitive, radar-based system. In the US-alone, for nonfatal falls, Medicare paid approximately $28.9...